MYLERAN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Estonia, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Tunisia.

Active ingredients

The drug MYLERAN contains one active pharmaceutical ingredient (API):

1	Busulfan UNII G1LN9045DK - BUSULFAN
	Busulfan is a potent cytotoxic agent and a bifunctional alkylating agent. In aqueous media, release of the methanesulphonate groups produces carbonium ions which can alkylate DNA, thought to be an important biological mechanism for its cytotoxic effect.
	Read more about Busulfan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYLERAN Film-coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AB01	Busulfan	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AB Alkyl sulfonates
Discover more medicines within L01AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1128J
CA	Health Products and Food Branch	00004618
EE	Ravimiamet	1005006
FR	Base de données publique des médicaments	64700734
HK	Department of Health Drug Office	03799
IL	מִשְׂרַד הַבְּרִיאוּת	4404
LT	Valstybinė vaistų kontrolės tarnyba	1001323
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	50871
NL	Z-Index G-Standaard, PRK	1872
NZ	Medicines and Medical Devices Safety Authority	2763
PL	Rejestru Produktów Leczniczych	100045175
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W58856001, W58856002
TN	Direction de la Pharmacie et du Médicament	1233011
US	FDA, National Drug Code	76388-713